Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cadiflu Tetra
- Development stage
- Unknown
- Lead developer
- Cadila Pharmaceuticals
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**Cadiflu Tetra** is a Cadila Pharmaceuticals quadrivalent seasonal influenza vaccine approved by the Drug Controller General of India for active immunization against influenza in adults and children. It uses virus-like particle technology comprising hemagglutinin, neuraminidase, and matrix protein 1 from four influenza A and influenza B strains. The nonreplicating particles mimic viral external structure without intact viral genetic material, inducing protective immune responses intended to reduce influenza illness, severity, and transmission. It is administered by intramuscular injection. ([cadilapharma.com](https://cadilapharma.com/media/press-releases/cadila-pharmaceuticals-introduces-innovative-quadrivalent-influenza-vaccine))
- Brand names
- Cadiflu Tetra
- Other names
- Cadiflu-TetraCadiflu Tetra Vaccine
02
Targets
HA (Hemagglutinin)M1 (Muscarinic acetylcholine receptor M1)Neuraminidase
Beyond the preview
Go deeper on Cadiflu Tetra.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cadiflu Tetra.